![]() | |
| Names | |
|---|---|
| IUPAC name
N-Ethyl-3-methoxy-2-methyl-1,2,3,4-tetradehydro-17-norretinamide | |
| Systematic IUPAC name
(2E,4E,6E,8E)-N-Ethyl-8-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenamide | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
| ECHA InfoCard | 100.054.613 |
| EC Number |
|
| KEGG | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C23H31NO2 | |
| Molar mass | 353.49774 |
| Pharmacology | |
| D10AD05 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
Motretinide is an anti-acne preparation and aromatic analog of retinoic acid.[1]
References
- ↑ Zouboulis, C. C. (2001). "Retinoids--which dermatological indications will benefit in the near future?". Skin Pharmacology and Applied Skin Physiology. 14 (5): 303–315. doi:10.1159/000056361. PMID 11586072.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
